Acrux is a specialty pharma company with a successful track record of developing and commercialising a pipeline of transdermal and topically applied pharmaceutical products. Drawing on 25 years of experience, Acrux has successfully marketed through licensees a number of products worldwide with emphasis on the United States. Acrux is formulating and developing a range of products by leveraging its highly skilled workforce, on-site laboratories, GMP manufacturing suite, technical, clinical and commercial experience to bring affordable products to market. Acrux encourages collaboration and is well positioned to discuss commercial partnering and product development opportunities.
Looking for a particular Acrux employee's phone or email?
Acrux Questions
The Acrux annual revenue was $7.6 million in 2026.
John Warmbrunn is the CEO and Managing Director of Acrux.
34 people are employed at Acrux.
Acrux is based in Melbourne, Victoria.
The NAICS codes for Acrux are [32541, 62151, 62, 325, 32, 621, 6215, 3254].
The SIC codes for Acrux are [28, 283].
Top Acrux Employees
-
John Warmbrunn
CEO and Managing Director at Acrux
Merricks Beach, VIC, AU13 -
Joanna Johnson
CFO and Company Secretary at Acrux
Melbourne, VIC, AU2 -
Mark Hyman
Technical and Project Director at Acrux
Melbourne, VIC, AU43 -
24
-
Mohan Vallipuram
Regulatory Affairs Manager at Acrux
Melbourne, VIC, AU13 -
Sharon Consiglio
HR and Facilities Manager at Acrux
Melbourne, VIC, AU2 -
Nghi Chau
Formulation Scientist at Acrux
Clayton, VIC, AU1 -
Jason Bloxham
Senior Project Manager at Acrux
Melbourne, VIC, AU3 -
Hainian Zhou
Scientist at Acrux
Moorabbin, VIC, AU
Related Companies
